 RESEARCH TRIANGLE PARK, N.C., March 30, 2021 GLOBE NEWSWIRE -- Liquidia Corporation NASDAQ: LQDA Liquidia or the Company today announced that Treprostinil Injection, a generic form of Remodulin, will soon be available for subcutaneous SC administration to treat patients diagnosed with pulmonary arterial hypertension PAH. 